Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-10

Clinical Trial Update: Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 trial comparing azithromycin plus chloroquine versus sulfadoxine-pyrimethamine plus chloroquine for uncomplicated Plasmodium falciparum mala…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin + Chloroquine
  • Sulfadoxine-Pyrimethamine + Chloroquine

Snippet

Sponsor: Pfizer | Conditions: PLASMODIUM FALCIPARUM MALARIA | Phase 2, Phase 3 | Status: COMPLETED